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AR T!CLES
THE MEDICAL, LEGAL, AND ETHICAL CONSIDERATIONS
OF HUMAN ORGAN TRANSPLANTATIONS
The progress of medical science in the field of organ transplantation has had to concern itself 'with a three-fold problem:
the actual medical difficulties involved in the surgical procedures
and post-operative care; the legal issues raised when death occurs; and, the ethical considerationsinherent in the decision-making process prior to the donor's death and the donee's surgery.
Of utmost importance is the determination of the time of death.
Medical progress has made outdated the dictionary definition of
death. A new definition is needed to overcome the many problems
in this area.
CARL

E. WASMuTH, M.D., J.D.*

In many countries of Europe, it was the custom to conduct a postmortem examination upon the body of each patient who died while confined in an institution. That this custom still influences the thinking of
many physicians practicing in those areas became evident in one of the
early symposia sponsored by the Ciba Foundation, and held in London,
England in 1966. After this conference, one of the participants stated:
"At postmortem a doctor would have the right to remove an organ
from a person who is dead unless there had been some intimation during
the life of that person that he did not wish it to be so." 1 This statement
was made in reply to the author's presentation of the essential points
now contained in the Uniform Anatomical Gift Act which has been
adopted by many jurisdictions in the United States.
At the Ciba Symposium, it was interesting to note that this group of
physicians, in their discussions, endorsed the suggested statute presented
by Lord Kilbrandon, the moderator of the Assembly, as follows:
*B.S., University of Pittsburgh, 1935; M.D., University of Pittsburgh, 1939; J.D,
Cleveland-Marshall Law School, 1959. Presently, Dr. Wasmuth is Senior Consultant,
Department of Anesthesiology, Cleveland Clinic Hospital, and Adjunct Professor of
Law, Cleveland-Marshall College of Law.
1. CIBA FOUNDATION SYMPOSIUM, ETHICS IN MEDICAL PROGRESS:
ENCE TO TRANSPLANTATION 160 (1966).
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In any designated hospital it shall be lawful to remove from a
dead person any organ required for medical or scientific purposes
unless the hospital authorities have reason to believe that the
deceased in his lifetime had forbidden this to be done, provided
2
that such removal shall not disfigure the dead body.
Lord Kilbrandon continued, "You have to realize that we will never
have an act of Parliament which will define death; that is a medical
3
question."
The European attitude concerning the sanctity of the human body
and the personal rights and privileges of a person differs remarkably
from that currently held in the United States. For the most part,
therefore, any discussion of the legal and ethical considerations of
organ transplantation must be limited to the attitude existing in the
United States. As stated above, when presented before the Ciba Symposium, 4 the concept of the Uniform Anatomical Gift Act did not
receive the full endorsement of the Symposium. The substantive content, the legal philosophy, and the intent were designed and written to
satisfy the requirements of the American jurisdictions.
In the ensuing years, several symposia and meetings have considered
every possible aspect of the problems involved in transplantation: the
rights of the donor (living or dead), the rights of the recipient, the
time of death, as well as the ethical problems involved. Recently,
Daedalus" dedicated an entire issue to the problem of the time of
death, transplantation, and human experimentation. Literature is replete with articles, both legal and medical. The culmination of these
investigative efforts now appears. Transplantation operations are being
conducted in medical centers in many parts of the world. The technical
problems involved in the surgical procedures were overcome many
years ago. Indeed, it is not the technical aspects that cause concern to
the medical profession but rather the complex legal, moral, and religious
questions that have evolved. Most participating physicians now understand the legal and moral responsibilities placed upon them. Armed
with this knowledge, they circumvent the many potential pitfalls when
they participate in these operations. The public also has been exposed
to the great advantages of transplantation of organs, and in most jurisdictions has participated actively in the support of legislative efforts
2. Id. at 213.
3.Id.
4. Id. at 102.
5. Ethical Aspects of Experimentation'with Human Subjects, 98 DArALus 219 (1969).
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to create the legal right and procedural avenue for donation of organs
which are to be removed upon death of the donor. Families too, when
one of their members has died, usually are sympathetic and seldom
refuse permission for removal of organs from the deceased for transplantation into a living recipient. Thus, much time and effort has
been expended in discussing these non-medical problems concerning
organ transplantation. In no aspect of the practice of medicine is the
complete cooperation of all involved more necessary than in the performance of the transplantation of organs.
MEDICAL CONSIDERATIONS

For centuries, man has been intrigued by the concept of transplanting
body parts from a healthy individual into another persons whose parts
have been destroyed by disease or injury.' The medical literature contains many references to legends of the middle ages which describe
attempts to transfer extremities from slaves or benevolent donors to
persons who had suffered the loss of such parts. In the light of present
knowledge, it is not difficult to understand why, if indeed the operations were carried out, that failure ensued.
Early in the twentieth century, the techniques were developed making it possible to transplant tissue from one person to another. The
transplantation of corneas and bone is now accepted surgical procedure.
In recent years transplantation of kidneys, and, with some reservation,
hearts, has been accomplished in the human. The transplantation of
hearts is now under reassessment and reevaluation. Survival rates of
recipients have been somewhat less than optimal. Moreover, the acquisition of a viable heart leads to searching questions such as exactly when
did the death of the donor occur, and what are the rights of the survivor and next of kin?
One of the great medical problems still not solved is the rejection
phenomenon. It has long been known that the body may reject transplanted tissues. The greater the genetic difference between the donor
and the recipient, the more rapid and vigorous is the rejection reaction.
Organs transplanted from an animal to a human (heterotransplantation)
is seldom successful. Currently, the use of baboons is being employed
in cross-circulation experiments with patients in hepatic failure. However, these experiments may be utilized only on patients who have
6. Wasmuth & Stewart, Medical and Legal Aspects of Human Organ Transplantation,
14 CLBV.-MAR. L. REv. 442 (1965).
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both the appropriate blood and tissue type. Unfortunately, such patients constitute a very small segment of the population. Transplantation
procedures involving human donors and recipients who are not re-,
lated (homotransplantation) are successful under certain circumstances. In humans, blood groups (commonly referred to as ABO)
are routinely determined in the laboratories. In the first instance, the
recipient and donor must coincide as to ABO groups and then, with
the more complicated and newer techniques further agree as to tissue
types. New and highly specific techniques are now being developed.
Great hope is currently being placed upon the efficacy of tissue typing,
and several medical centers have been established in the United States
to service all institutions participating in organ transplantation operations. In the future, tissue typing may become as commonly accepted
as blood typing and cross-matching. As the tests become more exact
with experimentation and tissue typing becomes readily available, organs from either living or dead donors can be more precisely matched
with the recipients. Hopefully, then, use of immunosuppressive drugs
will become less necessary.
It is generally accepted that the transplantation of certain tissues
causes little if any rejection in the recipient. As an illustration, corneas
can be removed from the eyes of a deceased person hours after death
and transplanted to another person without the development of a
rejection. Rejection seldom occurs when bone, obtained from one person, is used to correct a skeletal defect in another person. When considering the possibility of transplanting tissues, such as the kidney,
liver, heart, and pancreas, however, the specificity of tissue typing becomes vitally important. Those tissues, unless matched accurately, are
rejected actively by the recipient. Thus, physicians involved in transplantation operations are confronted not only with the legal and moral
problems, but indeed medical problems that at the present cannot be
fully overcome.
In transplantation of paired organs, such as kidneys, it has become
an accepted medical procedure for a living person to undergo surgical
removal of a kidney for transplantation into another. Under such circumstances, sufficient time exists for adequate study of the health
of the donor and the compatibility of the tissues of the donor and of
the recipient.
In the situation in which the donor is a recently deceased person,
time is of the essence. To obtain viable tissue, the organs must be
removed from the cadaver donor as soon as possible after death. Ques-
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dons immediately arise: When is the person dead? Who can pronounce
this person dead? Who can give consent for the removal of an organ
for transplantation? Who may remove this organ? May tissue typing
studies to the donor be carried out before the time of his death? These
and a myriad of other questions confront the surgical team.
When death occurs, and circulation ceases, tissue death in the organs
proceeds. As time passes, viability decreases. Unless prior studies have
been made to determine the tissue compatibility of potential recipient
and potential donor, sufficient time may not be available to do so before
transplantation. If such studies have been made, then the question arises
as to whether the studies were done in anticipation of death and for the
possible transplantation of organs. The ante-mortem study may be
construed as evidence that those in charge of the potential recipient
were possibly influenced in their therapeutic endeavors for the dying
patient.
Generally, in hospitals with transplantation programs, the treatment
of a dying patient is under the sole and exclusive jurisdiction of the
treating physician. In no event may he be a member of or participate
in the transplantation procedure should his patient die and become a
donor. Likewise, no member of the transplantation team may participate in the treatment of the potential donor or in the determination
of the time of death. Medical ethics places this solely under the jurisdiction of the treating physician and he alone has the right to determine
when the patient is dead or the moment when medical life-maintaining support may be discontinued. In most instances, the patient has
contracted with the treating physician for medical treatment in his
illness and therefore has placed his life in the physician's hands. It is
not unusual, however, for the treating physician, in serious and terminal
illnesses, to seek consultation with other physicians. Thus, the treating physician does share this responsibility and seldom makes the determination without the advice of others.
With medical progress in tissue typing and the control of rejection
phenomena by immunosuppressive agents, the success rate of transplantation operations is improving. Renal transplantations, however,
were first carried out successfully on patients in whom there was little
or no possibility of development of the rejection phenomenon. In 1954,
the kidney from a healthy twin was successfully transplanted into
the body of his ailing identical twin. Surgically, the technique for
transplantation had been perfected many years before. It was the
rejection phenomenon that had hindered further progress. In the
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case of identical twins, it is evident that their tissues must be compatible inasmuch as both twins originated from the same cell. Thus,
since the tissues were genetically identical, an organ transplanted from
one to the other would not be rejected.
In Masden v. Harrison,7 one twin had suffered irremediable damage
to both kidneys and as a result was in renal failure. Only hemodialysis,
or the use of the artificial kidney, kept that twin alive. But, while
lifesaving, this treatment was palliative only. A cure was only possible
if a kidney from the healthy twin could be transplanted into the ailing twin. The twins had not reached the age of majority and immediately the question of consent for the surgical procedures arose. The
parents of the sick child had the right to grant permission for the implantation of the kidney, but the healthy twin, not being of age, could
not give permission or contract for this operation. It became doubtful
whether or not the parents could give permission for removal of a
healthy organ from a healthy child. Several interesting legal questions
were raised: May a person consent to the intentional or voluntary
maiming of his own body? May a minor consent to an operation?
May the parents of a child consent to an operation upon a healthy
child which cannot possibly be of any benefit to him, and, in fact,
might be to his detriment?
Before proceeding with the operations, the physicians and the institution in which the operations were to be performed, considered it necessary to have a declaratory statement from the courts. Because of
the near emergency nature of the issue, application was made to the
Supreme Judicial Court of Massachusetts for a declaratory decree. The
court, after hearing the testimony of a highly qualified psychiatrist,
stated that if the healthy twin were not permitted the opportunity to
donate one of his kidneys to his brother and he died, the healthy twin
would suffer a great emotional impact. This psychological trauma would
be further aggravated by the realization that it had been within his
power to save the life of his brother had the operation been performed.
The court, therefore, decreed that "the defendant [the hospital and
physicians] may operate upon the body of Leonard Masden by removing one of his kidneys and transplanting it into the body of the twin
brother, Leon, without incurring any civil liability to Leonard or any
criminal prosecution, if such operation is conducted in a proper manner and without negligence." 8 Thus resolving the legal complexities
7. Equity No. 865 (Mass. Sup. Jud. Ct., June 12, 1957).
8. Id.
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inherent in the case, the transplantation of a kidney without the fear
of rejection phenomenon became possible. To the author's knowledge,
both twins are alive today.
Since few patients with renal failure have an identical twin standing by, need for medical research into the rejection phenomenon and
development of immunosuppressive agents remains a problem of great
magnitude.
Much has been written concerning the utilization of artificial organs. Kolff :and his associates at the Cleveland Clinic for many years
worked on the development of artificial hearts. To date, however,
Kolff's experiments at the University of Utah, and experiments of
others in various medical centers have not produced an organ equal
to or comparable with a heart taken from a human be-mg. Numerous
problems remain unresolved. Among these are the rejection of the
heart by the host body, the durability of the driving mechanism and
of the material from which the artificial heart is made, the reliability
of the mechanical structure, and the effect upon the blood which flows
through and is pumped by the artificial organ. There is little doubt,
however, that eventually with the improvement in materials and power
sources, many of the problems now existing in the use of artificial
organs can be overcome. With the development of tissue cultures,
however, it is perhaps possible that a new organ may be grown from
cells extirpated from the specific organ in the recipient's body. This
sounds like a science fiction, but with the rapid development of medical
science in recent years, one may not preclude this from the realm of
possibility or even probability. If it proves possible to grow such an
organ, then it becomes immaterial whether or not the rejection phenomenon is solved, but legal problems may still emerge.
LEGAL CONsIDERATIONs

Probably the most complex legal questions raised in regard to organ
transplantation involve the determination of the time of death and the
right of physicians to experiment on human beings. The question of
the time of death is of great importance to the prospective donor.
To deny that transplantation procedures were initially experimental
would verge upon the ridiculous. Currently, organ transplantation still
must be considered to be an experimental procedure, although it has
been performed several thousand times. Irrespective of the number
of times that a procedure has been performed experimentally and successfully upon animals, its application to a man must be considered
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an extension of investigative or research processes. Much has been
written in recent years concerning experimentation on human beings.
It seems as though an attempt has been made by some to deprecate
the investigative efforts of physicians interested in clinical research
activities. Therefore, when discussing the aspects involving organ transplantation, the problem of experimentation does arise. Most patients
undergoing such procedures are in desperate need and readily subject
themselves to the procedure in order potentially to save their lives.
Most would proceed regardless of the possible dangers inherent in the
technique, and in most instances the patient perceives the dangers ininvolved. Inasmuch as these procedures have been performed a limited
number of times, however, all complications possible might not yet be
known..According to the strict rules of an old, yet well-recognized
New York case, 10 a surgeon may not vary a given operative technique.
To do so is tantamount to experimentation, which may be considered
prima facie negligence. If the technique succeeds, however, the physician is exonerated. To ensure that a court will not hold him liable, a
surgeon must employ the technique successfully several times, thus establishing its safety. Under such a rule, all responsibility is placed upon the
physician when new techniques are employed.
The case law only requires that the physician exercise reasonable skill
and care. Certain restraints, however, must be placed upon medical
practitioners and investigators. The code of ethics of. the medical profession is of first importance. The physician's Oath of Hippocrates is
evidence of the high ideals of the practice of medicine transmitted
through the ages, but recently it has become necessary to set forth
basic rules to prevent the recurrence of any cruel and unscientific experimentation on man purportedly in the name of medical science. The
World Medical Association adopted the Declaration of Helsinki, 1
which, with certain modifications, has been adopted by the -House of
9. Beecher, Experimentation in Man, Report to the Council on Drugs, 169 J.A.M.A.
461 (1959); Schreiner, Liability in Use of Investigational Drugs, 185 J.A.M.A. 259
(1963); See Address by Crawford Morris, Human Testing and the Courtroom, National
Academy of Sciences Conference on the Use of Human Subjects in Evaluating the
Safety of Food Chemicals, in Washington, D.C., Nov. 29, 1966.
10. Carpenter v. Blake, 60 Barb. 488 (N.Y. 1871), rev'd on other grounds, 50 N.Y.
696 (1872). See also Landon v. Humphrey, 9 Conn. 209, 23 Am. Dec. 333 (1832); Richy
v. West, 23 111. 385 (1866); Billinger v. Craigue, 31 Barb. 534 (N.Y. 1860).
11. See Appendices A and B infra.
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Delegates of the American Medical Association, making it the official declaration of that association.
The intent of these declarations can be summed up in the official
declaration of the American Medical Association: "The health of my
patients will be my first consideration ....

Any act or advice which

could weaken the physical or mental resistance of a human being may
be used only in his interest." 12
The responsibilities of a physician who is performing a new and
hazardous surgical operation or administering an agent to a patient will
vary almost with the type of patient being treated. As an illustration,
investigation of new drugs is often attempted on a normal subject, such
as the physician himself, or on his assistants. In this instance, the normal
subject is not a patient of the experimenter, but, in fact, a volunteer
and may be termed the human guinea pig. He has volunteered his body
for the experimentation in the spirit of the research or for monetary
compensation. For example, during periods of war, conscientious objectors have volunteered for participation in medical studies, submitting
themselves for investigative programs; in many studies, volunteers of
penal colonies have been sought because they constitute a highly controlled population and, in certain instances, prisoners make ideal subjects for investigation.
While physicians must continue to recognize their legal responsibilities and liabilities, due consideration must be given to the patient,
his welfare, and, indeed, his wishes. Patients who are suffering the
ravages of complete renal shutdown or terminal heart failure are anxious
to accept the risks inherent in the surgical procedure for the transplantation of an organ. It matters little to them whether it is an experimental or an investigative procedure. Even in the absence of such
extenuating circumstances, however, a physician does have legal authority to institute a variation of an accepted surgical procedure without incurring liability. A somewhat similar situation was litigated in
Salgo v. Leland Stanford University,'a when the dosage of a drug administered to the patient during a surgical procedure was at variance
with the dosages listed in the package insert from the manufacturer.
Although this case involved the use of a pharmaceutic agent, the analogy
is clear. The question arose as to whether or not this variant constituted
grounds for malpractice on the basis of experimentation. The court in
its decision stated that because the physician departed from the custo12. AMERICAN MmDIcAL ASSOCIATION, JUDICIAL OPINIONS AND
13. 154 Cal. App. 2d 560, 317 P.2d 170 (Dist. Ct. App. 1957).

REPORTS

(1966).
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mary practice followed by physicians of standing in the locality did
not in and of itself cause the act to be an experimentation, and therefore the permission of the patient was not necessarily required. Liberties have been assumed in attempting to draw a parallel between the
use of experimental drugs and the surgeon's knife. There are few rules
of law, statutory regulations, or court decisions that outline the full
authority of the surgeon as to details of surgical technique, and that
specifically delineate the conduct of the surgical team. As in the administration of research drugs, patients must be protected against unnecessary and unsound surgical experimentation. 14 For the most part
surgical investigators are usually on the staffs of large medical centers
or research institutions, and such physicians are not tempted to try
unfounded and unscientific experimental procedures that have not been
carefully thought out and amply developed in animal experimentation.
Historically, the classic advocate of the above procedure is Dr. William
Beaumont, one of the great investigators, though not a surgeon, who
made landmark contributions to medicine by his treatment and observations of gastric fistula, resulting from a gunshot wound, in Alexis
St. Martin, now his famous patient.' 5
In recent years the doctrine of informed consent has been introduced
into the legal literature. "Informed consent" can best be described by
the words: duty to forewarn the patient. "Informed consent" denotes
that the patient understands the situation probably as well as the physician or the surgeon. The duty of the physician to forewarn is the
responsibility that the physician carries to warn the patient of possiblecomplications in possibly hazardous operations. In regard to the average
patient, undergoing procedures considered to be usual or standard, the
physician may not wish to explain to the patient all of the possible
complications. If this were a requirement, few patients would dare to
undergo an operation, and would thereby be denied its benefit. Many
complications are possible, yet seldom occur. The courts have stated
that the possible courses of treatment should be explained to the patient when more than one course is available. Thus, from a practical
standpoint, any legal doctrine requiring the recitation of all possible
catastrophic possibilities inherent in a surgical procedure would not
only be inconsiderate (because they do at least in theory exist) but
14. C. WASMuTH, LAw AND THE SURGICAL TEAM 323-32 (1969).
15. W. BEAUMoNr, EXPERIMENTS AND OBSERVATIONS ON THE GASTRIC JUICE AND THE
PHYSIOLOGY OF DIGESTIoN (Dover ed. 1959).
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in fact might deny the patient the benefits of modern surgical treatment.
In the case of organ transplantation, a new, and still considered to
be an experimental procedure, the doctrine of informed consent places
upon the physician still another burden. In Natanson v. Kline, 6 the
Kansas Supreme Court held that the physician had a duty to explain
the complications, particularly in regard to a new, experimental, and
hazardous technique. In this case, it was a question of whether the patient would or would not undergo radiation therapy after undergoing
mastectomy for cancer of the breast. At that time, radiation by cobalt
teletherapy was a new procedure. According to the decision in the
Natanson case, however, the physician should have explained to the
patient that a surgical process for cure had been carried out; the decision to undergo additional therapy should have been left to the
patient. Applying this to transplantation, all of the possible complications of the surgical procedure and the subsequent administration of
the immunosuppressive agents are still considered to be in the realm of
experimentation and are somewhat hazardous. The question arises then:
Is the physician to assume the responsibility for these if they occur,
or, does the patient assume some of the liability?
As an illustration, in recent months several reports in the medical
literature referred to the appearance of fibrosarcoma, a cancerous condition of the fibrous tissue of the transplanted kidney. Whereas the
neoplastic cells were not detected before transplantation, nonetheless
they were present subsequent to the use of the immunosuppressive drugs
and other agents. Whether or not these procedures were related to
this sequence has not been determined scientifically. Forewarning the
patient of this condition would have been impossible, as up to this
time its occurrence was not known to medical science. Yet strictly
interpreted, the duties placed upon the physician by the doctrine of
informed consent require that he forewarn the patient of 'that possible occurrence. It is probable that even if the patient were forewarned of these dire consequences, most if not all would readily agree
to undergo implantation of a kidney. The alternative is not at all attractive.
TIME OF DEATH

At this stage of development, the clinical results of transplantation
of an organ from a living donor are considerably better than the re16. 187 Kan. 186, 354 P.2d 670 (1960).
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suits obtained when the organ was removed from a cadaver donor.
There are several reasons. In the case of the living donor, time is available to perform adequate tissue typing to determine whether or not
the tissues of the donor will be compatible with those of the recipient.
When the donor has just died, sufficient time may not be available to
perform these studies adequately. In order to transplant a viable organ,
it must be removed from the deceased- donor as soon after death as
is possible. Lack of circulation of blood results in hypoxia and acidosis
within the organ, and the cells are thus damaged or killed. Such damage is usually irremediable.
Several institutions are now developing facilities for the preservation
of organs.17 This will permit necessary time to carry out tissue-typing
procedures so that the organ may be transplanted to a person with
whom it is compatible. Once these facilities are available, then time is no
longer an essential factor. At the moment of death, the organs can be
removed from the donor, and with sterile precautions placed in the
organ preservation unit to await the identity of the future recipient.
With these facilities, the necessity will be obviated for subjecting a
healthy patient to an operation to remove a healthy organ. Much of this
depends upon the availability of cadaver organs.
In many jurisdictions, where the Uniform Anatomical Gift Act has
been adopted, a person during his lifetime has the right to will his body or
any part thereof for transplantation purposes. From a practical standpoint,
however, the permission to perform this operation upon the deceased must
be obtained from the survivors or next of kin. Particularly is this so,
when, even though a proper consent or permission had been signed by
the deceased, the surviving spouse or member of the family strenuously
objects to any procedure to desecrate the deceased human body.
Whether or not the statutory provisions would prevail over the case
law is relatively unimportant. The invasion by the physician of the
survivor's rights, particularly in situations such as organ transplantation, might be considered to be quite indiscreet. Thus, while the physician may have a valid legal right, the opposition of the family might
well be the overwhelming and indeed the controlling action. The death
of a relative is wrought with great emotion. The needs of a stranger
who requires an organ from the deceased relative may not be persuasive to the survivors. To exercise a legal right to invade the body
17. At the Cleveland Clinic Foundation, the Organ Preservation Laboratory is
equipped with highly specialized equipment to preserve kidneys extirpated from deceased donors.
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of the deceased over the objection of the family might well precipitate
new case law.
The entire program of transplantation is dependent upon the availability and procurability of organs, and then their preservation until
transplantation. Sources of organs consist of patients who have undergone death of the brain but who still are "alive" according to the
classic sense in that the heart is still beating and they are breathing
or are being maintained artificially by a ventilator. In other instances,
the patients are admitted to the emergency room of a hospital, the
victims of automobile accidents, and are dead upon arrival. Still other
sources of organs are the bodies of those who have died as the result
of criminal acts.
The bodies of victims of criminal acts are, perhaps, not suitable for
transplantation purposes, inasmuch as in most instances criminal litigation ensues in the prosecution of the defendant criminal. In most jurisdictions, the coroner or medical examiner takes jurisdiction over the
body of the deceased. It is conceivable that if the organs involved are
not all associated with, or are not directly involved in the cause of death
of the victim, that such could be removed and placed in the organ
preservation unit. Inasmuch as some authorities still rely upon the
heartbeat as an indicator of whether or not life exists in the body, however, it is extremely difficult to explain how a heart transplanted from
the victim into another in which it continues to beat and maintain life
could ever have been determined to have been dead. Therefore, the
defense of the criminal will be that inasmuch as the heart was still
beating in the body of the recipient, the person who removed the heart
for purposes of transplantation actually killed the victim of the crime.
In this situation, the determination of the time of death becomes critically important.
In the event that the prospective donor is a patient who is dying,
and inasmuch as the organs to be transplanted must be removed from
that person as near as possible to the time of death, the determination
of that moment of death is likewise critical. Dorland's Illustrated
Medical Dictionary defines death as "[Ihe apparent extinction of life,
as manifested by the absence of heart beat and respiration." I With
the technological advances in medicine, it is possible to maintain by
mechanical means both the heartbeat and the respiration. A cardiac
pacemaker, with a self-contained power source, can be implanted under the skin of the trunk of the body and the wires connected to the
18.

DoRLAN's ILLusTRATED MEDicAL DICTIONARY

387 (24th ed. 1965).

19701

ORGAN TRANSPLANTATIONS

heart muscle. By rhythmic discharge of the electric current from this
pacemaker, the heart is stimulated to contract, thus maintaining circulation of the blood. In certain individuals, "life" as classically defined
is extended by artificial means. Likewise, the significant advances in
the ventilatory equipment now permit physicians, particularly in the
intensive care units of hospitals, to maintain respiratory excursions in
patients who have suffered respiratory arrest. Thus, in many instances
death is thwarted by the simple expedience of supporting by mechanical means the two vital processes described in the above definition,
the absence of which is defined as death. Many clinical illustrations are
available that will serve as examples. It becomes patently clear that
when respiratory arrest persists long enough, the patient will become
asphyxiated. As a direct result of the accompanying hypoxia, the
heart will stop: death then is said to occur. Likewise, should the heart
stop for a long enough period, respiratory excursions also will stop.
Modem medicine, however, may not accept, to the exclusion of all
others, the absence of the heartbeat and the respiration as the signs of
death. Consider the person who has suffered a cardiac arrhythmia that
progresses to ventricular fibrillation. Ordinarily, and in the past, this
condition was fatal. In the present state of medical science, when detected soon enough (before cerebral damage has occurred) ventricular
fibrillation can be stopped by the use of a defibrillator. This instrument
is designed to discharge a predetermined surge of direct current through
especially designed electrodes into the chest (and heart) of the patient.
The heart is thus shocked into standstill and, in many instances, will
revert to a normal rhythm or at least one that will support life. Most
of these patients have no heartbeat or respiration. According to the
dictionary definition, death has occurred, but, the condition of many
patients has been reverted and they are enjoying life. The cessation of
heartbeat, however, may not be detected as soon as it occurs. Not infrequently the decreasing circulation houses relative hypoxia in organs,
and thus compromises viability of those tissues. When resuscitative
procedures are not at once successful, and despite ventilation with oxygen-rich gases, viability of cerebral tissue may be compromised. Resuscitation of a person who has undergone severe damage of the brain
will result in a person who will survive only in an unconscious vegetative state.
Many persons, other than physicians, have witnessed the condition
of those who have suffered irremedial damage of the brain from massive cerebral hemorrhage, subarachnoid hemorrhage, and severe

WILLIAM AND MARY LAW REVIEW

[Vol. 11:636

cerebral trauma. In former years, those patients lingered until their
hearts stopped or their respirations ceased due to the trauma to the
brain, increase in intracranial pressure, or herniation of the brain stem.
Though the patient might have been unconscious and the brain irrevocably damaged for extended periods, death was said to occur only
when the respiration and heartbeat ceased. As mentioned before, with
the facilities available today, physicians may utilize mechanical devices
to maintain ventilation, and should the heart falter, it is possible to apply the mechanical pacemaker to assure continued heartbeat. Although
these two vital processes are supported, the damaged condition of the
brain is not improved. The damage to the brain, whether from physical
trauma or from pressure, is permanent and the patient will remain unconscious irrespective of the fact that a heartbeat and respiration do
exist. Is this patient not dead? To continue life (heartbeat and repiration) in such patients condemned to a state of coma is merely a triumph of protoplasmic resuscitation.
It is axiomatic in the law and traditional in medicine that upon the
treating physician is placed the responsibility of the patient's life. In
former years, this physician was most commonly the "family doctor."
With the many changes occurring in the system of delivery of health
care services and with the distinct tendency towards specialization, few
families now rely on only one physician for medical care. Liability
therefore is assumed by the physician who is treating the patient. Upon
him the law places the duty to exercise reasonable skill and diligence
in the treatment of the patient and according to the standards of medical practice. Upon him the law places the responsibility to treat his
patient, to cure a disease, to preserve his life, and to guard his welfare. Upon him, also, is placed the responsibility to abandon treatment
and life-sustaining measures when further efforts would, in his opinion,
be in vain. Most treating physicians wish not to assume these responsibilities solely; in difficult cases, consultation with other physicians is
sought. Upon the treating physician, though, rest the ultimate decision
for treatment and the final responsibility.
When death of a patient is imminent, or when it becomes apparent
that a patient will not regain consciousness because of damage to the
brain, the treating physician seeks consultation with other physicians
and with the patient's family. Should the consultants agree that further
support would continue life, but that the cerebral damage would not
be reversed, the treating physician may then advise the discontinuance
of such support. Death in fact has already occurred. To stop the venti-
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lator is to eliminate the artificial life-sustaining respiration. The heart
will soon cease to beat. The patient then is dead cerebrally and dead
according to the classic definition of death.
Many criteria have been set out for the determination of death. In
his article several years ago, Doctor Hamlin set forth conditions offered for certifying brain death in association with cardiorespiratory activity artificially sustained by mechanical aids:
(1) No spontaneous respiration for a minimum of 60 minutes.
(2) No reflex response (superficial, deep, organic, etc.).
(3) No change in the heart rate or ocular or carotid sinus pressure.
(4) EEC-flat line with no rhythms in any leads for at least 60
minutes of continuous recording. No EEG response to auditory or somatic stimuli or to electrical stimulation. Longer
periods of total flat recordings some hours apart may be
preferred by some.
(5) Normal basic laboratory data inchiding electrolyte pattern.
(6) Share responsibility for pronouncement of death with other
colleagues. 19
At the concluson of his article he stated that:
if complete EEG [electroencephalogram] silence could gain acceptance as proper grounds for withholding fruitless efforts of
resuscitation, some of the nobility in death would be preserved
where it has frequently been forfeited through our slavish and
superstitious refusal to acknowledge that St. Peter is at the gate
or Sharon at the Cross. More solace thereby would be granted
to relatives who under current hospital practice often have to
await the grim and foregone verdict until the final beat of the
20
dying heart has been re.corded.
In summary, it is now generally accepted in the medical community
that death can no longer be defined as the cessation of the heartbeat
and respiration. Clinical death is evident when these processes of respiration and circulation have ceased, and as a direct result have caused
other irreversible damage such as cellular death. Only when cellular
death occurs in a viable organ may a physician declare such a person
to be dead. Thus, at the moment when a physician determines that
19. Hamlin, Life or Death by EEG, 190 J.A.M.A. 112, 114 (1964).
20. Id. at 114.
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the heart of a patient cannot be resuscitated death becomes inevitable.
Further efforts to resuscitate the patient may be abandoned. Life, as
we understand it, without a functioning myocardium is impossible.
Likewise, respirations can be supported by the automatic ventilators.
In some patients, however, the physical condition of lungs defy and
prevent adequate gas exchange and perfusion. Therefore, irrespective
of mechanical ventilation, asphyxia continues. It becomes evident to all
concerned that these patients are beyond salvage. Sooner or later
cellular death of other parts will follow. The gradual onset of cellular
death proceeds with the inexorable passage of time. Cellular death does
not proceed at the same rate in all tissues. Some tissues deprived of
oxygen are traumatized sooner than others. It is a recognized fact
that the kidneys can undergo hypoxic conditions for rather extensive
periods. The brain, deprived of oxygen for only a few minutes, suffers
irremedial damage.
It has been stated that it is the prerogative of the treating physician
to determine the time of death. The methods used in arriving at this
conclusion also are the prerogative of the treating physician. The determination of the time of death is a matter of medical judgment. The
treating physician must satisfy his professional conscience and the legal
requirements of reasonable medical certainty.
These are limits set by the law, and beyond this point the law should
not inquire. When the physician, utilizing whatever methods are available, has determined that continued support of these vital physiological
processes by artificial means becomes an agonizing and useless prolongation of a false hope of recovery, it become his responsibility to
withdraw such support.
It now becomes obvious that the dictionary definition of death is
anachronistic. In a recent case in which the court addressed itself to
this question of the time of death, no physicians were available when
the events occurred to determine the cause or the time of death. Therefore, the court was forced to receive testimony of those (not physicians) who witnessed the events. The court suggested that death is
not a continuing event, but is an event that takes place at a precise
time. 1 While the facts of the case may support such a determination,
the decision must not be impressed upon others where highly skilled
physicians are in attendance in the scientific environment of a hospital
center. The situation facing the court in which no physician was in at21. Smith v. Smith, 229 Ark. 579, 317 S.W.2d 275 (1958).
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tendance, is far different from that situation in an intensive care unit
where the patient is surrounded by many medical experts and the latest
medical equipment. The definition of death here must be based upon
medical judgment and must take into consideration many other scientific criteria. These circumstances are in vivid contrast to the situations
in which lawyers are arguing the time of death in a case where none
of the participants had even seen the body of the deceased, much less
the circumstances causing the death.
The medical profession has set forth the criteria for the diagnosis
of death based upon the present status of medical and scientific knowledge. Because of the continuing scientific advances, these criteria, from
time to time may be changed. Therefore, they should not be ensconced
in the immutable language of statute by legislative fiat, nor cast in
bronze by the decisions of the court. The criteria for the diagnosis of
the time of death may be changed, but this too must be determined by

medical, not legal, judgment.
APPENDiX

A*

THE DECLARATION OF HELSINKI

[The Declaration of Helsinki, consisting of recommendations guiding
doctors in clinical research, was adopted by the World Medical Association in 1964 and endorsed by eight leading professional organizations including the American Medical Association. Following is the text of the
declaration, followed by the AMA Ethical Guidelines for Clinical Investigation.]
Introduction
It is the mission of the doctor to safeguard the health of the people. His
knowledge and conscience are dedicated to the fulfillment of this mission.
The Declaration of Geneva of The World Medical Association binds
the doctor with the words: "The health of my patient will be my first
consideration" and the International Code of Medical Ethics which declares that "Any act or advice which could weaken physical or mental
resistance of a human being may be used only in his interest."
Because it is essential that the results of laboratory experiments be applied to human beings to further scientific knowledge and to help suffering humanity, The World Medical Association has prepared the following recommendations as a guide to each doctor in clinical research. It
must be stressed that the standards as drafted are only a guide to physicians

"Supra note

1 at 216-18. (August 19, 1947).
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all over the world. Doctors are not relieved from criminal, civil, and ethical responsibilities under the laws of their own countries.
In the field of clinical research a fundamental distinction must be recognized between clinical research in which the aim is essentially therapeutic
for a patient, and the clinical research, the essential object of which is
purely scientific and without the therapeutic value to the person subjected
to the research.
I. Basic Principles
1. Clinical research must conform to the moral and scientific principles
that justify medical research and should be based on laboratory and animal
experiments or other scientifically established facts.
2. Clinical research should be conducted only by scientifically qualified persons and under the supervision of a qualified medical man.
3. Clinical research cannot legitimately be carried out unless the importance of the objective is in proportion to the inherent risk to the
subject.
4. Every clinical research project should be preceded by careful assessment of inherent risks in comparison to foreseeable benefits to the subject or to others.
5. Special caution should be exercised by the doctor in performing
clinical research in which the personality of the subject is liable to be altered by drugs or experimental procedure.
II. Clinical Research Combined with Professional Care
1. In the treatment of the sick person, the doctor must be free to
use a new therapeutic measure, if in his judgment it offers a hope of
saving life, reestablishing health, or alleviating suffering.
If at all possible, consistent with patient psychology, the doctor should
obtain the patient's freely given consent after the patient has been given
a full explanation. In case of legal incapacity, consent should also be procured from the legal guardian; in case of physical incapacity the permission of the legal guardian replaces that of the patient.
2. The doctor can combine clinical research with professional care,
the objective being the acquisition of new medical knowledge, only to the
extent that clinical research is justified by its therapeutic value for the
patient.
III. Nontherapeutic Clinical Research
1. In the purely scientific application of clinical research carried out
on a human being, it is the duty of the doctor to remain the protector of
the life and health of that person on whom clinical research is being carried out.
2. The nature, the purpose, and the risk of clinical research must be explained to the subject by the doctor.
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3a. Clinical research on a human being cannot be undertaken without
his free consent after he has been informed; if he is legally incompetent,
the consent of the legal guardian should be procured.
3b. The subject of clinical research should be in such a mental, physical,
and legal state as to be able to exercise fully his power of choice.
3c. Consent should, as a rule, be obtained in writing. However, the
responsibility for clinical research always remains with the research worker;
it never falls on the subject even after consent is obtained.
4a. The investigator must respect the right of each individual to safeguard his personal integrity.
4b. At any time during the course of clinical research the subject or
his guardian should be free to withdraw permission for research to be continued.
The investigator or the investigating team should discontinue the research if in his or their judgment, it may, if continued, be harmful to the
individual.
We, the undersigned medical organizations, endorse the ethical principles set forth in the Declaration of Helsinki by the World Medical Association concerning human exe-rimentation. These principles supplement
the principles of medical ethics to which American physicians already subscribe.
American Federation for Clinical Research
American Society for Clinical Investigation
Central Society for Clinical Research
American College of Physicians
American College of Surgeons
Society for Pediatric Research
American Academy of Pediatrics
American Medical Association
ETHICAL GUIDELINES FOR CLINICAL INVESTIGATION

(Adopted by House of Delegates, American Medical Association,
November 30, 1966)
At the 1966 Annual Convention of its House of Delegates, the American
Medical Association endorsed the ethical principles set forth in the 1964
Declaration of Helsinki of the World Medical Association concerning
human experimentation. These principles conform to and express fundamental concepts already embodied in the Principles of Medical Ethics of
the American Medical Association.
The following guidelines, enlarging on these fundamental concepts, are
intended to aid physicians in fulfilling their ethical responsibilities when
they engage in the clinical investigation of new drugs and procedures.
1. A physcian may participate in clinical investigation only to the extent that his activities are a part of a systematic program competently de-
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signed, under accepted standards of scientific research, to produce data
which is scientifically valid and significant.
2. In conducting clinical investigation, the investigator should demonstrate the same concern and caution for the welfare, safety, and comfort
of the person involved as is required of a physician who is furnishing
medical care to a patient independent of any clinical investigation.
3. In clinical investigation primarily for treatmentA. The physician must recognize that the physician-patient relationship exists and that he is expected to exercise his professional judgment
and skill in the best interest of the patient.
B. Voluntary consent must be obtained from the patient, or from
his legally authorized representative if the patient lacks the capacity to
consent, following: (a) disclosure that the physician intends to use an
investigational drug or experimental procedure, (b) a reasonable explanation of the nature of the drug or procedure to be used, risks to be expected, and possible therapeutic benefits, (c) an offer to answer any inquiries concerning the drug or procedure, and (d) a disclosure of alternative drugs or procedures that may be available.
i. In exceptional circumstances and to the extent that disclosure
of information concerning the nature of the drug or experimental procedure or risks would be expected to materially affect the health of the
patient and would be detrimental to his best interests, such information
may be withheld from the patient. In such circumstances such information
shall be disclosed to a responsible relative or friend of the patient where
possible.
ii. Ordinarily, consent should be in writing, except where the
physician deems it necessary to rely upon consent in other than written
form because of the physical or emotional state of the patient.
iii. Where emergency treatment is necessary and the patient is
incapable of giving consent and no one is available who has authority to
act on his behalf, consent is assumed.
4. In clinical investigation primarily for the accumudation of scientific

knowledgeA. Adequate safeguards must be provided for the welfare, safety,
and comfort of the subject.
B. Consent, in writing, should be obtained from the subject, or from
his legally authorized representative if the subject lacks the capacity to
consent, following: (a) a disclosure of the fact that an investigational
drug or procedure is to be used, (b) a reasonable explanation of the nature of the procedure to be used and risks to be expected, and (c) an offer to answer any inquiries concerning the drug or procedure.
C. Minors or mentally incompetent persons may be used as subjects
only if:

19701

ORGAN TRANSPLANTATIONS

i. The nature of the investigation is suclh that mentally competent adults would not be suitable subjects.
ii. Consent, in writing, is given by a legally authorized representative of the subject under circumstances in which an informed and
prudent adult would reasonably be expected to volunteer himself or his
child as a subject.
D. No person may be used as a subject against his will.
APPENDix

B*

THE NUREMBURG CODE

1. The voluntary consent of the human subject is absolutely essential.
This means that the person involved should have legal capacity to
give consent; should be so situated as to be able to exercise free power
of choice without the intervention of any element of force, fraud,
deceit, duress, overreaching or other ulterior form of constraint or
coercion; and should have sufficient knowledge and comprehension
of the elements of the subject matter involved as to enable him to
make an understanding and enlightened decision. This latter element
requires that before the acceptance of an affirmative decision by the
experimental subject there should be made known to him the nature,
duration, and purpose of the experiment; the methods and means by
which it is to be conducted; all inconveniences and hazards reasonably to be expected; and the effects upon his health or person which
may possibly come from his participation in the experiment.
The duty and responsibility for ascertaining the quality of the consent rests upon each individual who initiates, directs, or engages in
the experiment. It is a personal duty and responsibility which may not
be delegated to another with impunity.
2. The experiment should be such as to yield fruitful results for the good
of society, unprocurable by other methods or means of study, and
not random and unnecessary in nature.
3. The experiment should be so designed and based on the results of
animal experimentation and a knowledge of the natural history of
the disease or other problem under study that the anticipated results
justify the performance of the experiment.
4. The experiment should be so conducted as to avoid all unnecessary
physical and mental suffering and injury.
5. No experiment should be conducted where there is at a-priori reason to believe that death or disability or disabling injury will occur;
except, perhaps in those experiments where the experimental physicians are also serving as subjects.
Supra note 1 at 219-21.
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6. The degree of risk to be taken should never exceed that determined
by the humanitarian importance of the problem to be solved by the
experiment.
7. Proper preparations should be made and adequate facilities provided to
protect the experimental subject against even remote possibilities of
injury, disability, or death.
8. The experiment should be conducted only by scientifically qualified
persons. The highest degree of skill and care should be required through
all stages of the experiment of those who conduct or engage in the
experiments.
9. During the course of the experiment the human subject should be at
liberty to bring the experiment to an end if he has reached the physical
or mental state where continuation of the experiment seems to him to
be impossible.
10. During the course of the experiment the scientist in charge must be
prepared to terminate the experimenting at any stage, if he has probable cause to believe, in the exercise of good faith, superior skill, and
careful judgment required of him, that continuation of the experiment
is likely to result in injury, disability, or death to the experimental
subject.

